Recor Medical ex-CEO Lara Barghout joins Medtronic
Published . Updated .
Barghout, who led Recor when it won FDA approval of the first renal denervation treatment for hypertension, is the new president of Medtronic’s Interventional Cardiology Therapies business.
Directly affected
- MDT Medtronic
Named in this report.
Indirectly affected
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BBIO BRIDGEBIO PHARMA INC
GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DVA DaVita HealthCare Partners, Inc.
GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- GEHC GE HEALTHCARE TECHNOLOGIES I
GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Barghout, who led Recor when it won FDA approval of the first renal denervation treatment for hypertension, is the new president of Medtronic’s Interventional Cardiology Therapies business.
Source: MedTech Dive
The price since 16 Sep 2026: Medtronic (MDT) versus the S&P 500
Since the first closing price after “Recor Medical ex-CEO Lara Barghout joins Medtronic,” Medtronic (MDT) is -0.01%. The S&P 500 fund (SPY) is +0.52% over the same days, a -0.52% difference versus the market.
Filings that name Medtronic (MDT) around 16 Sep 2026
- Gilbert Cisneros sell BridgeBio Pharma (BBIO) ($1,001 - $15,000). That is 13 days after publication, inside 30 days. The filing is listed beside the story “Recor Medical ex-CEO Lara Barghout joins Medtronic.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 5 days before publication, inside 30 days. The filing is listed beside the story “Recor Medical ex-CEO Lara Barghout joins Medtronic.”
- Kevin Hern sell Medtronic (MDT) ($15,001 - $50,000). That is 23 days before publication, inside 30 days. The filing is listed beside the story “Recor Medical ex-CEO Lara Barghout joins Medtronic.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 44 days before publication, inside 60 days. The filing is listed beside the story “Recor Medical ex-CEO Lara Barghout joins Medtronic.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 48 days before publication, inside 60 days. The filing is listed beside the story “Recor Medical ex-CEO Lara Barghout joins Medtronic.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 48 days before publication, inside 60 days. The filing is listed beside the story “Recor Medical ex-CEO Lara Barghout joins Medtronic.”
- Richard Dean McCormick sell Medtronic (MDT) ($1,001 - $15,000). That is 48 days before publication, inside 60 days. The filing is listed beside the story “Recor Medical ex-CEO Lara Barghout joins Medtronic.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 55 days before publication, inside 60 days. The filing is listed beside the story “Recor Medical ex-CEO Lara Barghout joins Medtronic.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “Recor Medical ex-CEO Lara Barghout joins Medtronic”
Companies carried with this story
- MDT Medtronic
In “Recor Medical ex-CEO Lara Barghout joins Medtronic,” Medtronic (MDT) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names MEDTRONIC PLC in the headline; GA resolved that company to MDT
- ACHC Acadia Healthcare
Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence in the 16 Sep 2026 story “Recor Medical ex-CEO Lara Barghout joins Medtronic.” Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence in the 16 Sep 2026 story “Recor Medical ex-CEO Lara Barghout joins Medtronic.” Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
For “Recor Medical ex-CEO Lara Barghout joins Medtronic,” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
For “Recor Medical ex-CEO Lara Barghout joins Medtronic,” BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
In “Recor Medical ex-CEO Lara Barghout joins Medtronic,” Davita (DVA) is linked, with no stored direction, medium confidence. Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- GEHC GE HealthCare Technologies
GE HealthCare Technologies (GEHC) is linked, with no stored direction, medium confidence in the 16 Sep 2026 story “Recor Medical ex-CEO Lara Barghout joins Medtronic.” Reason on file: GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “Recor Medical ex-CEO Lara Barghout joins Medtronic” reaches Medtronic (MDT)
On 16 Sep 2026, “Recor Medical ex-CEO Lara Barghout joins Medtronic” is the story that connects Medtronic (MDT) to this story.
For Medtronic (MDT), the reason on file says The reported development directly names MEDTRONIC PLC in the headline; GA resolved that company to MDT
A second company, Acadia Healthcare (ACHC), is listed for a different reason: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates and price levels for Medtronic (MDT)
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. MDT traded between 85.22 and 96.47 across 20 sessions. The latest close on file is 92.79.
A simple score for Medtronic (MDT)
46 out of 100
“Recor Medical ex-CEO Lara Barghout joins Medtronic” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.